Fresh Rounds

Renovare Therapeutics, Inc. funding

Renovare Therapeutics, Inc., a biotechnology company based in Boulder, CO (founded 2026), filed a Form D with the SEC on October 2, 2026 and reported $100K raised of a $1M offering.

Amount raised$100K
Offering size$1M
Filed with the SECOctober 2, 2026
First saleSeptember 14, 2026
IndustryBiotechnology
SecuritiesOptions or warrants
LocationBoulder, CO
Founded2026
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Colorado